The World Health Organization (WHO) is a specialised agency of the United Nations (UN) based in Geneva. It is the UN's coordinating authority on international public health.
- We are actively involved in discussions on public health and on protecting intellectual property, e.g. for improved access to drugs
- We are committed to ensuring intellectual property has a good reputation as an incentive, in particular in relation to the development and therefore the availability of new drugs
- We advise the Swiss delegation, which is led by the Federal Office of Public Health (FOPH)
- We also play an active role in negotiating the relevant resolutions
A working group of the Swiss government (co-led by the IPI) published an Overview on the implementation and contribution of Swiss actors (pdf) in May 2011 on the WHO's Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.
06.07.2018 | IPI
The founding of the sic! Foundation for intellectual property, information and competition law.
08.06.2018 | IP news
Winners of the European Inventor Award 2018 announced: The Swiss physicist Ursula Keller receives lifetime achievement award
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office